Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ · Healthcare
Oramed Pharmaceuticals Inc. Shareholder Equity 2016–2025
Oramed Pharmaceuticals Inc. annual shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Oramed Pharmaceuticals Inc. shareholder equity as of December 31, 2025: 199.7M, a 21.93% increase year-over-year.
- Oramed Pharmaceuticals Inc. shareholder equity for 2025 were 199.7M, a 21.93% increase from 2023.
- Oramed Pharmaceuticals Inc. shareholder equity for 2023 were 163.8M, a 7.91% increase from 2022.
- Oramed Pharmaceuticals Inc. shareholder equity for 2022 were 151.8M, a 31.13% increase from 2021.
- Oramed Pharmaceuticals Inc. shareholder equity for 2021 were 115.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Oramed Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $200 |
| 2023 | $164 |
| 2022 | $152 |
| 2021 | $116 |
| 2020 | $33 |
| 2019 | $19 |
| 2018 | $31 |
| 2017 | $19 |
| 2016 | $26 |
Oramed Pharmaceuticals Inc. Shareholder Equity — FAQ
Oramed Pharmaceuticals Inc. (ORMP) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ORMP's shareholder equity history?
The chart and table above show Oramed Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.